The Use of Betrixaban for Extended Prophylaxis of Venous Thromboembolism Events in Hospitalized, High-Risk Patients
Paul P. Dobesh, PharmD;Tania Ahuja, PharmD;George A. Davis, PharmD;Hugh Fatodu, MBA, RPh;William H. Francis, MBA, RPh;Frank P. Hull, MD;Gary L. Johnson, MD, MS, MBA;Joshua D. Lenchus, DO, BSPharm;Jacqueline Glee Lenoir, PharmD;Claudette McPherson, RN, BSN;Jeffrey Nemeth, PharmD, MPA;Ralph J. Riello III, PharmD November 17th 2018ArticleARTICLES